Congenital heart defects represent the most common birth defect in the United States (US), af fecting 1 in 100 children born. They account for 6% of all infant deaths and 15% of all pediatric hospitalization expenses in the US each year. Advancements in surgical and catheter-based interventions and medical therapies for congenital heart disease (CHD) have dramatically increased the survival rates for infants and children, resulting in more than 90% of children with CHD surviving into adulthood. The growing population of children and adults living with CHD requires equitable access to multidisciplinary, life-long care. Geographic location, race, ethnicity, and socioeconomic status should not impact access to that care.


The Congenital Health Public Health Consortium (CHPHC) is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS). The outputs of the CHPHC are solely the responsibility of the CHPHC and do not necessarily represent the official views of, or an endorsement by, the member organizations of the CHPHC, CDC/HHS, or the U.S. Government. 

Last Updated

08/05/2025

Source

American Academy of Pediatrics